They’re stuck in a downward spiral.
The generic drug industry in the U.S. has saved people billions and billions of dollars. But it faces new economic pressure today.
The Federal Trade Commission says companies like CVS Caremark, Express Scripts and OptumRx are artificially driving up prices for medications.
The hope is that over-the-counter sales could make the devices more affordable to millions of Americans who would benefit from them.
The limited plan would, for the first time, give Medicare the power to negotiate prices directly with pharmaceutical companies.
